Informazioni
Non ci sono recensioni
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Infectious Complications in Cancer Patients
Stosor, Zembower
Editore
Springer
Anno
2014
Pagine
511
ISBN
9783319042190
155,00 €
- Identifies unique aspects of the management of infectious diseases in the cancer patient
- Aid to optimization of the overall care of patients with malignancies
- Written by internationally renowned experts in the field
While advances in both the treatment of cancer and the management of its complications have led to significant improvement in patient survival, infections remain a significant cause of morbidity and mortality in patients with neoplastic disease. In this patient population, infection risk results from a complex interplay between the host’s underlying immunodeficiencies, local tumor effects, and treatment-induced immunosuppression. New chemotherapeutic approaches and antimicrobial prophylaxis and treatment practices continue to shape the spectrum of infections in these patients. Clinicians who treat infections in cancer patients are continually challenged by the emergence of new pathogens and by the increasing antimicrobial resistance of established ones.
The aim of this book, is to emphasize unique aspects of management of infectious diseases in the cancer patient. With the increasing complexity of this patient population, optimal management requires a multidisciplinary approach, and this fact is fully reflected in the contributions, all from recognized authorities in the field. Ultimately, it is hoped that this volume will assist specialists in infectious diseases and haematology/oncology in the diagnosis, management, and prevention of infection and optimization of the overall care of patients with malignancies.
Contents
Host Impairments in Patients with Neoplastic Diseases . . . . . . . . . . . . 1
J. Peter Donnelly, Nicole M. A. Blijlevens
and Walter J. F. M. van der Velden
Epidemiology of Infections in Cancer Patients . . . . . . . . . . . . . . . . . . 43
Teresa R. Zembower
Bacterial Pathogens. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
John W. Wilson
Fungal Infections in Cancer Patients . . . . . . . . . . . . . . . . . . . . . . . . . 129
Michael Angarone
Advances in the Management of Viral Infections . . . . . . . . . . . . . . . . 157
Jack W. Hsu and John R. Wingard
Neutropenic Fever and Sepsis: Evaluation and Management. . . . . . . . 181
Kenneth V. I. Rolston
Respiratory Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203
Evan J. Anderson
Enteric Infections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237
Michael Wang and Stuart Johnson
Central Nervous System Infections in Cancer Patients
and Hematopoietic Stem Cell Transplant Recipients. . . . . . . . . . . . . . 253
Michael J. Hoffman and Valentina Stosor
Dermatologic Infections in Cancer Patients . . . . . . . . . . . . . . . . . . . . 299
Mona Gandhi, Joaquin C. Brieva and Mario E. Lacouture
Infections in Patients with Leukemia and Lymphoma. . . . . . . . . . . . . 319
Vicki A. Morrison
Infectious Complications of Stem Cell Transplantation . . . . . . . . . . . . 351
Charulata Ramaprasad and Kenneth J. Pursell
Infections Associated with Solid Malignancies . . . . . . . . . . . . . . . . . . 371
Sarah H. Sutton
Antimicrobial Agents, Drug Adverse Reactions and Interactions,
and Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 413
Ximena Millan, Victoria Muggia and Belinda Ostrowsky
Infection Control and Prevention Considerations . . . . . . . . . . . . . . . . 463
Titus L. Daniels and Thomas R. Talbot
Prevention of Infection in Cancer Patients . . . . . . . . . . . . . . . . . . . . . 485
Diana Pomakova and Brahm H. Segal
